Shape the Future of ACS! We want your feedback about the ACS brand and how we can serve you better into the future. Take the Survey!

Online vs. In-Person: Networking as a Medicinal Chemist

ACS Webinars

KRAS is one of the most frequently mutated oncogenes in human cancer. Despite more than three decades of research, indirect approaches targeting KRAS-mutant cancers have largely failed to show clinical benefit, and direct approaches have been stymied by the apparently ‘undruggable’ nature of KRAS.

Join Brian Lanman of Amgen as he outlines the strategies used to overcome these challenges, the screening approaches employed to identify starting points for these efforts, and the optimization challenges overcome in the identification sotorasib, the first direct KRAS G12C therapeutic to enter human clinical testing.

What You Will Learn

  • Why networking is essential for a successful career in medicinal chemistry
  • How to approach in-person vs. virtual networking with proven advice from leaders in the field
  • What tips and tricks for virtual networking provide results and how you can get started now


Ronny Priefer
Full Professor, Department of Pharmaceutic Sciences,
Massachusetts College of Pharmacy and Health Sciences University

Kelly Chibale
Professor of Organic Chemistry,
University of Cape Town, South Africa

Maria Laura Bolognesi
Full Professor, Department of Pharmacy and Biotechnology Alma Mater Studiorum, in Italy
Associate Editor of Journal of Medicinal Chemistry

Lorraine Clark
Managing Editor,
ACS Publications

Co-Produced With

Related Content